Please turn JavaScript on
BioProcessing Journal icon

BioProcessing Journal

Follow BioProcessing Journal's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for BioProcessing Journal.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

BioProcessing Journal: BioProcessing Journal – Trends & Developments in BioProcess Technology | Since 2002

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.33 / day

Message History

By Ellab

Volume 25, Open Access (August 2026)

Life sciences companies face strict regulatory expectations for maintaining product quality across manufacturing, storage, and distribution. Operating within environments where temperature, humidity, and other conditio...


Read full story

By Keith L. Carson

Volume 8, Issue 4 (Winter 2009/2010)

M&As continue at a dizzying pace even while so many organizations are just trying to hang on. Apparently some of the biggest firms still have excess money or access to cheap money, and they would rather spend it...


Read full story

By Keith L. Carson

Volume 12, Issue 4 (Winter 2013/2014)

I’ve seen little to tell me the major biopharma firms, or the larger supply firms, have learned anything. They’re stuck on the concepts of slashing vital resources—such as R&D and capacity—to “do deals” plus pa...


Read full story

By Keith L. Carson

Volume 16, Issue 1 (Spring 2017)

When I go to a therapeutic protein meeting, it’s very hard for me to hear these products referred to as “drugs.” But since they are being regulated by CDER, it’s a little easier to swallow. However, calling viral gene v...


Read full story

By Keith L. Carson

Volume 15, Issue 4 (Winter 2016/2017)

There are so many exciting things happening in the biotech industry. As we have all seen, antibody products are being approved for more and more cancer applications, in addition to those for auto-immune diseases, w...


Read full story